Related Experiment Video
Updated: Aug 21, 2026

Establishment and Evaluation of a Risk Prediction Model for Pathological Escalation of Gastric Low-Grade Intraepithelial Neoplasia
Published on: February 16, 2024
[Gastroduodenal ulcer associated with Helicobacter pylori]
1Département des maladies de l'appareil digestif et de la nutrition Hôpital Charles-Nicolle, Rouen.
Abstract:
Helicobacter pylori is associated with chronic peptic ulcer disease. The high prevalence of H. pylori infection tends to decrease in Western countries suggesting that the incidence of gastroduodenal ulcers not related to antiinflammatory drugs will fall. Abundant data support the leading role of H. pylori in peptic disease through dysregulation of acid production, induction of gastric metaplasia, and development of chronic gastritis. Endoscopy is the key to diagnosis, allowing direct assessment of H. pylori infection. H. pylori eradication is the major aim of peptic ulcer treatment, dramatically improving the recurrence of ulcers, although its efficiency should be controlled in various clinical situations.
Related Concept Videos
Peptic Ulcer Disease I: Introduction
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
Peptic Ulcer Disease II: Pathophysiology
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Peptic Ulcer
Gastritis II: Pathophysiology
Peptic Ulcer Disease I: Introduction
Peptic Ulcer Disease II: Pathophysiology

